Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation

Abstract

Neutrophil-independent macrophage responses are a prominent part of delayed-type immune and healing processes and depend on T cell-secreted cytokines. An important mediator in this setting is the phosphoprotein osteopontin, whose secretion by activated T cells confers resistance to infection by several intracellular pathogens through recruitment and activation of macrophages. Here, we analyze the structural basis of this activity following cleavage of the phosphoprotein by thrombin into two fragments. An interaction between the C-terminal domain of osteopontin and the receptor CD44 induces macrophage chemotaxis, and engagement of β3-integrin receptors by a nonoverlapping N-terminal osteopontin domain induces cell spreading and subsequent activation. Serine phosphorylation of the osteopontin molecule on specific sites is required for functional interaction with integrin but not CD44 receptors. Thus, in addition to regulation of intracellular enzymes and substrates, phosphorylation also regulates the biological activity of secreted cytokines. These data, taken as a whole, indicate that the activities of distinct osteopontin domains are required to coordinate macrophage migration and activation and may bear on incompletely understood mechanisms of delayed-type hypersensitivity, wound healing, and granulomatous disease.

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2002
Source ID
10.1189/jlb.72.4.752

Entities

People

  • Georg F. Weber
  • Harvey Cantor
  • Samer Zawaideh
  • Samy Ashkar
  • Sherry Hikita
  • Vikram A Kumar

Organizations

  • Dana–Farber Cancer Institute
  • Harvard Medical School
  • Illinois Department of Public Health
  • National Institutes of Health
  • United States Department of Defense

Tags

Fields of Study

  • Biology
  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.
  • Immunology
  • Oncology and Biomarker-Based Cancer Detection.